Buprenorphine And Naloxone Film
Product Images NDC 0378-8766

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0378-8766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine Hydrochloride Structural Formula (Image 01)

FDA Label Image

Naloxone Hydrochloride Structural Formula (Image 02)

FDA Label Image

Instructions For Use Figure 1 (Image 03)

FDA Label Image

Instructions For Use Figure 2 (Image 04)

FDA Label Image

Instructions For Use Figure 3 (Image 05)

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 06)

This is a set of instructions and warning labels for using and storing Buprenorphine and Naloxone Sublingual Film. The package contains 20 sublingual films, each containing 2.16mg of buprenorphine HCI and 0.51mg of naloxone HCI. The films are placed under the tongue or inside the cheek and should not touch. It is advised to keep the package away from children and call emergency medical care if accidently taken by a child. The storage temperature should be at 20° to 25°C. The lot number and expiration date are also included.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 07)

This is a description of instructions for properly taking Buprenorphine and Naloxone sublingual film, a medication used to treat opioid dependence. The text includes directions on how to administer the film under the tongue or inside the cheek as well as warnings to keep the medication out of reach of children and not to cut, chew or swallow the film. The medication should be stored at room temperature and each sublingual film contains 4.31mg of Buprenorphine HCI, equivalent to 4mg of Buprenorphine and 1.22mg of Naloxone HCI, equivalent to 1mg of Naloxone.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 08)

This is a description of a medication called Buprenorphine and Naloxone Sublingual Film, which is designed for individuals suffering from opioid addiction. The medication is administered by placing the film under the tongue and letting it dissolve. The text also includes instructions for pharmacists regarding the dosage and storage of the product. Additionally, the text warns parents to keep the medication out of children's reach.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 09)

This appears to be the label of Buprenorphine and Naloxone Sublingual Film, used for the treatment of opioid addiction. The label includes information about dosage, administration, and precautions, such as not cutting, chewing or swallowing the film. The label also includes a warning for accidental ingestion by children and lists equivalent doses of buprenorphine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.